课题基金 / 基金详情

Reversing CMV-induced gut damage to reduce inflammation and improve response to vaccine in people living with HIV

Reversing CMV-induced gut damage to reduce inflammation and improve response to vaccine in people living with HIV
逆转巨细胞病毒引起的肠道损伤,减少炎症并改善艾滋病毒感染者对疫苗的反应
批准号:
451733
负责人:
Routy Jean-Pierre
金额:
$42.91万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
未结题
起止时间:
2021-09-01 至 2025-09-01

项目摘要

项目成果

Routy Jean-Pierre的其他基金

相似基金

相关文献

中文摘要
翻译
目前用于对抗艾滋病毒感染的抗逆转录病毒疗法(ART)极大地改善了艾滋病毒感染者(PLWH)的生活。然而,PLWH患与年龄相关的疾病的风险更大,这些疾病与炎症和免疫功能障碍有关。
英文摘要
The current antiretroviral therapy (ART) used to fight HIV infection has dramatically improved the lives of people living with HIV (PLWH). Nevertheless, PLWH are at greater risks of age-related disorders which are linked to inflammation and immune dysfunc
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunosuppressive pathways and HIV reservoirs in tissues
Locking out HIV from CD4 T cells: A pilot study of the impact of anti a4b7 antibody (vedolizumab) on viral control following analytical treatment interruption
Transsexual people: The visible and invisible persona
The orchid study: A pilot assessment of viral reservoir and immune compartmentalization in testicular tissue of HIV-infected subjects
国内基金
海外基金
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
  • 批准号:
    81801389
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2018
  • 负责人:
    田茗源
  • 依托单位: